A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice

Nature Genetics

Volumn 38, Issue 8, 2006, Pages 926-930

  To, Minh D ^a   Perez Losada, Jesus ^a   Mao, Jian Hua ^a   Hsu, Jeff ^a,c   Jacks, Tyler ^b   Balmain, Allan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c XOMA Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN KRAS2; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GENETICS; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CHROMOSOME 6; CONTROLLED STUDY; FEMALE; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCUS; GENE SWITCHING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; HAPLOTYPE; KRAS2 GENE; LUNG ADENOMA; LUNG CANCER; LUNG TUMOR; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE K RAS; PAS1 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION;

ADENOMA; ALLELES; ANIMALS; CARCINOGENS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; LUNG NEOPLASMS; MALE; MICE; MODELS, GENETIC; MUTATION; ONCOGENES; PROTO-ONCOGENE PROTEINS P21(RAS); RISK FACTORS; URETHANE;

EID: 33746555367     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1836     Document Type: Article

References (30)

1. Gariboldi, M. et al. A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. Nat. Genet. 3, 132-136 (1993).
2. You, M., Candrian, U., Maronpot, R.R., Stoner, G.D. & Anderson, M.W. Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc. Natl. Acad. Sci. USA 86, 3070-3074 (1989).
3. You, M. et al. Mutagenesis of the K-ras protooncogene in mouse lung tumors induced by N-ethyl-N-nitrosourea or N-nitrosodiethylamine. Carcinogenesis 13, 1583-1586 (1992).
4. Ryan, J., Barker, P.E., Nesbitt, M.N. & Ruddle, F.H. KRAS2 as a genetic marker for lung tumor susceptibility in inbred mice. J. Natl. Cancer Inst. 79, 1351-1357 (1987).
5. Wang, M. et al. Fine mapping and identification of candidate pulmonary adenoma susceptibility 1 genes using advanced intercross lines. Cancer Res. 63, 3317-3324 (2003).
6. Manenti, G. et al. Haplotype sharing suggests that a genomic segment containing six genes accounts for the pulmonary adenoma susceptibility 1 (Pas1) locus activity in mice. Oncogene 23, 4495-4504 (2004).
7. Johnson, L. et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410, 1111-1116 (2001).
8. Jackson, E.L. et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15, 3243-3248 (2001).
9. You, M. et al. Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids. Proc. Natl. Acad. Sci. USA 89, 5804-5808 (1992).
10. Zhang, Z. et al. Positional cloning of the major quantitative trait locus underlying lung tumor susceptibility in mice. Proc. Natl. Acad. Sci. USA 100, 12642-12647 (2003).
11. Wang, M., Futamura, M., Wang, Y. & You, M. Pas1c1 is a candidate for the mouse pulmonary adenoma susceptibility 1 locus. Oncogene 24, 1958-1963 (2005).
12. Maria, D.A. et al. Pulmonary adenoma susceptibility 1 (Pas1) locus affects inflammatory response. Oncogene 22, 426-432 (2003).
13. Hennings, H. et al. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 14, 2353-2358 (1993).
14. Nagase, H. et al. Distinct genetic loci control development of benign and malignant skin tumours in mice. Nat. Genet. 10, 424-429 (1995).
15. Demant, P. Cancer susceptibility in the mouse: genetics, biology and implications for human cancer. Nat. Rev. Genet. 4, 721-734 (2003).
16. Dragani, T.A. 10 years of mouse cancer modifier loci: human relevance. Cancer Res. 63, 3011-3018 (2003).
17. Manenti, G., Falvella, F.S., Gariboldi, M., Dragani, T.A. & Pierotti, M.A. Different susceptibility to lung tumorigenesis in mice with an identical Kras2 intron 2. Genomics 29, 438-444 (1995).
18. Manenti, G. et al. Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression. Cancer Res. 57, 4164-4166 (1997).
19. Czarnomska, A. et al. Opposite effects of modifiers of the ApcMin mutation in intestine and mammary gland. Cancer Res. 63, 4533-4537 (2003).
20. Quintanilla, M., Brown, K., Ramsden, M. & Balmain, A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322, 78-80 (1986).
21. Guerrero, I., Villasante, A., Corces, V. & Pellicer, A. Loss of the normal N-ras allele in a mouse thymic lymphoma induced by a chemical carcinogen. Proc. Natl. Acad. Sci. USA 82, 7810-7814 (1985).
22. Li, J. et al. LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer. Oncogene 22, 1243-1246 (2003).
23. Diaz, R. et al. Inhibition of Ras oncogenic activity by Ras protooncogenes. Int. J. Cancer 113, 241-248 (2005).
24. Zhang, Z. et al. Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat. Genet. 29, 25-33 (2001).
25. Wang, Y. & You, M. Alternative splicing of the K-ras gene in mouse tissues and cell lines. Exp. Lung Res. 27, 255-267 (2001).
26. Bystrykh, L. et al. Uncovering regulatory pathways that affect hematopoietic stem cell function using 'genetical genomics'. Nat. Genet. 37, 225-232 (2005).
27. Schadt, E.E. et al. Genetics of gene expression surveyed in maize, mouse and man. Nature 422, 297-302 (2003).
28. Dragani, T.A. et al. Population-based mapping of pulmonary adenoma susceptibility 1 locus. Cancer Res. 60, 5017-5020 (2000).
29. Yanagitani, N. et al. Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11. Carcinogenesis 23, 1177-1183 (2002).
30. Beck, J.A. et al. Genealogies of mouse inbred strains. Nat. Genet. 24, 23-25 (2000).